TGTX
TG Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$55.85
−1.52%Leverage
- Debt / equity
- 1.25x
- Net debt / equity
- 0.45x
- Debt / assets
- 0.46x
- Debt / EBITDA
- 5.62x
- Net debt / EBITDA
- 2.03x
Liquidity & coverage
- Current ratio
- 4.27x
- Quick ratio
- 3.72x
- Cash ratio
- 2.06x
- Interest coverage
- 3.64x
- EBITDA / interest
- 3.58x
- Working capital
- $877.2M
Cash & dividend
- FCF / debt
- -0.00x
- Cash flow / debt
- -0.00x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026